Remdesivir Treats Covid-19

Video Blogs
Accumulating evidence suggests enthusiasm surrounding Remdesivir as a treatment for Covid-19 appears warranted.  Originally introduced as a treatment during the Ebola epidemic of 2013-2016, Remdesivir targeted the virus in laboratory studies and test animals.  However it offered only mediocre results in comparison to other drugs in a major trial sponsored by the WHO. During initial studies in conjunction with investigators from the CDC, NIAID and US Army Research Institute of Infectious Diseases, Remdesivir demonstrated significant activity against the coronavirus cause of the Middle East Respiratory Syndrome or MERS.  Due to the small number of patients and the restricted geographic area, human testing was not undertaken.  Not unexpectedly laboratory experiments of Remdesivir also revealed enhanced control of the related coronavirus resulting in Severe Acute Respiratory Syndrome or SARS.   Ebola Shortly after…
Read More

Hydroxychloroquine | Maybe For Coronavirus?

Video Blogs
Hydroxychloroquine Although hydyroxchloroquine received FDA marketing approval about 65 years ago, until recently it generated little interest.  Primarily indicated as therapy for systemic lupus erythematosus and rheumatoid arthritis, hydroxychloroquine remains among the top 150 prescription drugs in America.  In some circumstances hydroxychloroquine may also find use in treating or preventing malaria.  Hydroxychloroquine is a close relative of the slightly more toxic chloroquine. Laboratory Studies During the mid-1990s studies in the laboratory, not in humans, demonstrated hydroxychloroquine could inhibit growth of a wide array of RNA viruses including the causative agents of rabies, influenza, Dengue fever and some forms of hepatitis.  Other experiments suggested similar actions against bacteria and fungi.  In 2009 scientists observed an otherwise lethal exposure of newborn mice to coronavirus OC43 could be transformed into a survivable condition…
Read More